DK1284952T3 - Substituerede chalconer som terapeutiske kompositioner - Google Patents
Substituerede chalconer som terapeutiske kompositionerInfo
- Publication number
- DK1284952T3 DK1284952T3 DK01914064T DK01914064T DK1284952T3 DK 1284952 T3 DK1284952 T3 DK 1284952T3 DK 01914064 T DK01914064 T DK 01914064T DK 01914064 T DK01914064 T DK 01914064T DK 1284952 T3 DK1284952 T3 DK 1284952T3
- Authority
- DK
- Denmark
- Prior art keywords
- group
- 4alkyl
- compounds
- therapeutic compositions
- substituted
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C251/36—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C251/40—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C305/00—Esters of sulfuric acids
- C07C305/22—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings
- C07C305/24—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/017—Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/12—Esters of phosphoric acids with hydroxyaryl compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/90209—Oxidoreductases (1.) acting on NADH or NADPH (1.6), e.g. those with a heme protein as acceptor (1.6.2) (general), Cytochrome-b5 reductase (1.6.2.2) or NADPH-cytochrome P450 reductase (1.6.2.4)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Food Science & Technology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0007401.3A GB0007401D0 (en) | 2000-03-27 | 2000-03-27 | Substituted chalcones as therapeeutic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1284952T3 true DK1284952T3 (da) | 2006-10-30 |
Family
ID=9888505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01914064T DK1284952T3 (da) | 2000-03-27 | 2001-03-26 | Substituerede chalconer som terapeutiske kompositioner |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6787672B2 (da) |
| EP (1) | EP1284952B1 (da) |
| JP (1) | JP5235257B2 (da) |
| AT (1) | ATE330928T1 (da) |
| AU (1) | AU784609B2 (da) |
| CA (1) | CA2403900C (da) |
| CY (1) | CY1107519T1 (da) |
| DE (1) | DE60120962T2 (da) |
| DK (1) | DK1284952T3 (da) |
| ES (1) | ES2269360T3 (da) |
| GB (1) | GB0007401D0 (da) |
| NZ (1) | NZ521595A (da) |
| PT (1) | PT1284952E (da) |
| WO (1) | WO2001072680A1 (da) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0123777D0 (en) * | 2001-10-03 | 2001-11-21 | Cancer Res Ventures Ltd | Substituted chalcones as therapeutic agents |
| GB0123780D0 (en) * | 2001-10-03 | 2001-11-21 | Cancer Res Ventures Ltd | Substituted chalcones as therapeutic agents |
| CN1596240A (zh) * | 2001-12-19 | 2005-03-16 | 阿特罗吉尼克斯公司 | 查耳酮衍生物及其治疗疾病的用途 |
| EP1751115A4 (en) * | 2004-05-23 | 2010-10-20 | Gerard M Housey | THERAMUTEINMODULATOREN |
| KR100597871B1 (ko) * | 2004-06-08 | 2006-07-06 | 학교법인 영남학원 | 방향환을 함유하는 신규 프로페논 유도체 및 이를 함유하는 항염증제 |
| DE102006018988B3 (de) * | 2006-04-25 | 2007-08-09 | Nateco2 Gmbh & Co. Kg | Verfahren zur Herstellung eines Xanthohumol-haltigen Pulvers hoher Reinheit und dessen Verwendung |
| US7714025B2 (en) * | 2006-05-10 | 2010-05-11 | Arizona Biomedical Research Commission | Modified chalcone compounds as antimitotic agents |
| DK2219451T3 (da) | 2007-11-21 | 2015-01-12 | Oxigene Inc | Fremgangsmåde til behandling af hæmatopoietiske neoplasmer |
| GB0907551D0 (en) | 2009-05-01 | 2009-06-10 | Univ Dundee | Treatment or prophylaxis of proliferative conditions |
| WO2011009826A2 (en) | 2009-07-21 | 2011-01-27 | ADAMED Sp.z o.o. | Novel chalcone derivatives with cytotoxic activity |
| CN102397269B (zh) * | 2011-09-20 | 2015-01-07 | 温州医学院 | 查尔酮类化合物在制备抗炎药物中的应用 |
| KR101333735B1 (ko) * | 2011-11-01 | 2013-11-27 | 건국대학교 산학협력단 | 디페닐프로페논 화합물를 유효성분으로 포함하는 신경계 염증질환 예방 및 치료용 약학조성물 |
| CN103102283B (zh) * | 2011-11-09 | 2014-05-28 | 南京大学 | 一种查耳酮肟类化合物作为新型免疫抑制剂的制备方法与用途 |
| CN103664689A (zh) * | 2013-11-04 | 2014-03-26 | 南京大学 | 对癌细胞微管蛋白聚合有抑制作用的一类查尔酮肟衍生物及其制备方法 |
| KR101558500B1 (ko) * | 2014-02-26 | 2015-10-12 | 건국대학교 산학협력단 | 신규한 메톡시칼콘 유도체 및 그 항암제로의 용도 |
| EP3337495A4 (en) | 2015-08-18 | 2019-04-10 | Mateon Therapeutics, Inc. | USE OF VDA TO ENHANCE IMMUNOMODULATION THERAPIES AGAINST TUMORS |
| PE20210367A1 (es) | 2018-02-02 | 2021-02-26 | Maverix Oncology Inc | Conjugados de farmacos de molecula pequena de monofosfato de gemcitabina |
| CN115850048B (zh) * | 2022-12-01 | 2024-05-10 | 东南大学 | 一种合成2芳基丁烯酮类化合物的方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4279930A (en) | 1978-10-10 | 1981-07-21 | The Upjohn Company | Process for treating inflammation |
| JPS60237039A (ja) * | 1984-05-08 | 1985-11-25 | Nippon Oil & Fats Co Ltd | ベンザルアセトフエノン及びその誘導体の製造方法 |
| JPS6176433A (ja) | 1984-09-21 | 1986-04-18 | Toyobo Co Ltd | 新規なカルコン誘導体 |
| LU86715A1 (fr) | 1986-12-16 | 1988-07-14 | Oreal | Composition cosmetique contenant des derives hydroxyles de chalcone et son utilisation pour la protection de la peau et des cheveux contre les radiations lumineuses,nouveaux derives hydroxyles de chalcone utilises et leur procede de preparation |
| JPH02142717A (ja) | 1988-11-22 | 1990-05-31 | Kanebo Ltd | 養毛化粧料 |
| JPH05246932A (ja) | 1992-03-04 | 1993-09-24 | Nippon High Potsukusu:Kk | 3,4−ジヒドロキシカルコン誘導体 |
| US5430062A (en) * | 1992-05-21 | 1995-07-04 | Research Corporation Technologies, Inc. | Stilbene derivatives as anticancer agents |
| SK20396A3 (en) | 1993-08-19 | 1997-03-05 | Warner Lambert Co | Substituted 2(5h)furanone, 2(5h)thiophenone or 2(5h)pyrrolone derivatives and pharmaceutical compositions on their base |
| JPH08188546A (ja) | 1995-01-04 | 1996-07-23 | Kyowa Hakko Kogyo Co Ltd | カルコン誘導体 |
| GB9519490D0 (en) | 1995-09-25 | 1995-11-29 | Melvin William T | Use of a cytochrome P450 enzyme in tumour cells as a marker and target |
| AU7908098A (en) | 1997-06-26 | 1999-01-19 | Statens Serum Institut | Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones |
| GB9802522D0 (en) | 1998-02-06 | 1998-04-01 | Montford University De | Hydroxylation activated prodrugs |
| EP1051383B1 (en) | 1998-02-06 | 2004-07-28 | De Montfort University | Hydroxylation activated prodrugs |
| CA2395191A1 (en) | 1999-12-23 | 2001-06-28 | Tedman Ehlers | Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
-
2000
- 2000-03-27 GB GBGB0007401.3A patent/GB0007401D0/en not_active Ceased
-
2001
- 2001-03-26 PT PT01914064T patent/PT1284952E/pt unknown
- 2001-03-26 AT AT01914064T patent/ATE330928T1/de active
- 2001-03-26 DK DK01914064T patent/DK1284952T3/da active
- 2001-03-26 DE DE60120962T patent/DE60120962T2/de not_active Expired - Lifetime
- 2001-03-26 WO PCT/GB2001/001341 patent/WO2001072680A1/en not_active Ceased
- 2001-03-26 ES ES01914064T patent/ES2269360T3/es not_active Expired - Lifetime
- 2001-03-26 NZ NZ521595A patent/NZ521595A/en not_active IP Right Cessation
- 2001-03-26 US US10/239,757 patent/US6787672B2/en not_active Expired - Fee Related
- 2001-03-26 CA CA2403900A patent/CA2403900C/en not_active Expired - Fee Related
- 2001-03-26 JP JP2001570595A patent/JP5235257B2/ja not_active Expired - Fee Related
- 2001-03-26 EP EP01914064A patent/EP1284952B1/en not_active Expired - Lifetime
- 2001-03-26 AU AU39450/01A patent/AU784609B2/en not_active Ceased
-
2006
- 2006-09-20 CY CY20061101338T patent/CY1107519T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU784609B2 (en) | 2006-05-11 |
| US20030100538A1 (en) | 2003-05-29 |
| WO2001072680A1 (en) | 2001-10-04 |
| PT1284952E (pt) | 2006-11-30 |
| CA2403900A1 (en) | 2001-10-04 |
| ATE330928T1 (de) | 2006-07-15 |
| DE60120962T2 (de) | 2007-02-08 |
| JP5235257B2 (ja) | 2013-07-10 |
| US6787672B2 (en) | 2004-09-07 |
| AU3945001A (en) | 2001-10-08 |
| EP1284952A1 (en) | 2003-02-26 |
| DE60120962D1 (de) | 2006-08-03 |
| JP2003528842A (ja) | 2003-09-30 |
| ES2269360T3 (es) | 2007-04-01 |
| CY1107519T1 (el) | 2013-03-13 |
| CA2403900C (en) | 2011-02-08 |
| GB0007401D0 (en) | 2000-05-17 |
| NZ521595A (en) | 2005-04-29 |
| EP1284952B1 (en) | 2006-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1284952T3 (da) | Substituerede chalconer som terapeutiske kompositioner | |
| AP1422A (en) | 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent. | |
| ID27178A (id) | Senyawa aminosikloheksil eter dan penggunaannya | |
| ATE440603T1 (de) | 8-hydroxychinolinderivate | |
| WO2001064642A3 (en) | Benzamides and related inhibitors of factor xa | |
| DK1392714T3 (da) | Steroider som agonister for FXR | |
| PL369108A1 (en) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| WO2001056989A3 (en) | Inhibitors of factor xa | |
| BR0108893B1 (pt) | composiÇço farmacÊutica contendo derivados de azetidina, composto derivado de azetidina, e, processo para a preparaÇço de compostos. | |
| AUPR213700A0 (en) | Antiviral agents | |
| AR036100A1 (es) | Derivados de naftil benzofurano sustituidos, composiciones farmaceuticas y el uso de dichos derivados para la manufactura de medicamentos que son inhibidores del inhibidor-1 activador de plasminogeno (pai-1) | |
| MY143391A (en) | Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4) | |
| SE0101932D0 (sv) | Pharmaceutical combinations | |
| BRPI0111140B8 (pt) | forma polimórfica, uso da mesma, e, composição farmacêutica | |
| MXPA05011176A (es) | Derivados de carboxamida como agentes antidiabeticos. | |
| BR0005616A (pt) | 2-(3,5-bis-trifluormetil-fenil)-n-metil-n-(6-morfolin-4-i l-4-o-tolil-piridin-3-il)-isobutiramida | |
| WO2001057021A3 (en) | 2-[1H]-QUINOLONE AND 2-[1H]-QUINOXALONE INHIBITORS OF FACTOR Xa | |
| MXPA02002452A (es) | Agentes preventivos y terapeuticos para enfermedades de oftalmicas. | |
| DK1228758T3 (da) | Anvendelse af sulfodehydroabietinsyre til behandling af inflammatorisk tarmsygdom | |
| DE60114640D1 (en) | Antithrombosemittel | |
| UY25824A1 (es) | Antagonista del receptor de vitronectina | |
| WO2003028713A3 (en) | 3,4-methylenedioxy-substituted chalcones as therapeutic agents | |
| SE0004827D0 (sv) | Therapeutic compounds | |
| ES2284970T3 (es) | Compuestos amina 1,2- y 1,3-diol y su utilizacion para el tratamiento de alzheimer. | |
| BR0211127A (pt) | Utilização de um composto |